GN
Genprex, Inc.
GNPX · NASDAQ
$3.50 -2.78% (-$0.10)
1M -22.75%
Market Cap $1.73M
P/E Ratio -
Div. Yield -
ROE 163.13%
Bulios Fair Price
$3.96
13.1% upside
Current Price
$3.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GNPX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.12x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 29.03%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 163.13%
ROA 96.28%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 6.77x
Int. coverage -34.59x
Debt/Equity 0.00x
Stability
31 /100
Unstable EPS volatility 57.71%
Profitable years 0
Beta -0.89x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GNPX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ryan Confer
Employees
13
Headquarters
Austin
Upcoming events
02 DEC
Earnings
Upcoming earnings report